宣传报道过于理想研发难度大于预期世界上最舍得花钱做研发的制药公司瑞士罗氏,最近做了一个令业内震惊的决定:裁员6%,削减4600名员工。这是罗氏自金融风暴以来的首次大规模裁员。注定要受裁员影响的是罗氏从事RNAi研究开发的人员,因为在宣布裁 Rumors of overreaching and development are more difficult than expected The Roche, a pharmaceutical company most willing to spend money on research and development in the world, recently made a shocking decision in the industry to cut 6% and cut 4,600 employees. This is the first large-scale layoff of Roche since the financial turmoil. To be affected by layoffs Roche is engaged in research and development of RNAi personnel, because the announcement